CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 42 filers reported holding CASSAVA SCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $95,241 | -91.5% | 4,694 | -89.8% | 0.00% | -100.0% |
Q2 2023 | $1,126,351 | -63.5% | 45,936 | -56.1% | 0.00% | -42.9% |
Q4 2022 | $3,087,521 | +363.6% | 104,520 | +341.3% | 0.01% | +600.0% |
Q2 2022 | $666,000 | -92.2% | 23,682 | -89.6% | 0.00% | -87.5% |
Q1 2022 | $8,496,000 | +124.3% | 228,764 | +164.0% | 0.01% | +166.7% |
Q4 2021 | $3,787,000 | -85.0% | 86,662 | -78.8% | 0.00% | -88.9% |
Q3 2021 | $25,319,000 | -45.6% | 407,852 | -25.1% | 0.03% | -51.8% |
Q2 2021 | $46,529,000 | +146.2% | 544,585 | +29.5% | 0.06% | +100.0% |
Q1 2021 | $18,896,000 | +4388.4% | 420,383 | +580.4% | 0.03% | +2700.0% |
Q4 2020 | $421,000 | -70.3% | 61,789 | -49.8% | 0.00% | -75.0% |
Q3 2020 | $1,418,000 | +107.6% | 123,169 | -44.4% | 0.00% | +33.3% |
Q2 2020 | $683,000 | +1651.3% | 221,631 | +2210.8% | 0.00% | – |
Q1 2020 | $39,000 | +3800.0% | 9,591 | +6607.0% | 0.00% | – |
Q4 2019 | $1,000 | – | 143 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 143 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 143 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 143 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |